Ratings
0
Nobody has rated this yet. Be the first!
Works
2
Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes
Serial Measurement of High-Sensitivity Troponin I and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus in the EXAMINE Trial (Examination of Cardiovascular Outcomes With Alogliptin Versus Standard of Care).